Insulin resistance-associated hepatic iron overload

Area of Science:

• Hepatology
• Metabolic Disorders
• Genetics

Background:

• Hepatic iron overload is observed in metabolic conditions like insulin resistance syndrome (IRS) and nonalcoholic steatohepatitis (NASH).
• The specific nature of hepatic iron overload in these contexts remains incompletely understood.

Purpose of the Study:

• To investigate whether hepatic iron overload in metabolic conditions represents a distinct clinical entity.
• To characterize patients with unexplained hepatic iron overload.

Main Methods:

• Analysis of 161 patients with unexplained hepatic iron overload.
• Assessment of metabolic parameters (IRS, BMI, diabetes, hyperlipidemia), iron status (serum iron, transferrin saturation, liver iron concentration - LIC), HFE gene mutations (C282Y, H63D), and liver histology.
• Comparison of iron burden and metabolic factors across different genotypes and liver damage grades.

Main Results:

• The patient cohort was predominantly middle-aged males, with 94% having IRS.
• Elevated transferrin saturation was noted in 35% of patients, and liver iron concentration (LIC) ranged from 38 to 332 micromol/g.
• HFE gene mutations (C282Y, H63D) were more prevalent, particularly in compound heterozygotes, but did not significantly correlate with the degree of iron overload, except for a slightly higher burden in compound heterozygotes.
• Steatosis (25%) and NASH (27%) were present, with portal fibrosis in 62%.
• IRS, transferrin saturation, and LIC did not correlate with liver damage severity.
• Patients with steatosis/NASH showed higher serum ferritin and liver function test results, but similar LIC and HFE mutation frequencies compared to others.

Conclusions:

• Unexplained hepatic iron overload is consistently associated with IRS.
• Patients present with mild to moderate iron burden.
• The findings suggest a unique entity characterized by hepatic iron accumulation and metabolic dysfunction, irrespective of the degree of liver damage.